Patients with common variable immunodeficiency (CVID) requiring IV immunoglobulin (IVIG) therapy have poorer health-related (HR) QOL than individuals with other chronic diseases

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 461, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Therapeutic Strategies in Common Variable Immunodeficiency

By Sewell W.A.C.  

Drugs, Vol. 63, Iss. 13, 2003-01 ,pp. : 1359-1371

Adis International

Access to resources Recommend Favorite

A Review on Defects of Dendritic Cells in Common Variable Immunodeficiency

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 17, Iss. 2, 2017-09 ,pp. : 100-113

Bentham Science Publishers

Access to resources Recommend Favorite

Intravenous Immunoglobulin Replacement Therapy in the Treatment of Patients with Common Variable Immunodeficiency Disease: An Open-Label Prospective Study

By Kasztalska Karolina  

Clinical Drug Investigation, Vol. 31, Iss. 5, 2011-05 ,pp. : 299-307

Adis International

Access to resources Recommend Favorite

Comparison of Bone Mineral Density in Common Variable Immunodeficiency and X-Linked Agammaglobulinaemia Patients

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 17, Iss. 2, 2017-09 ,pp. : 134-140

Bentham Science Publishers

Access to resources Recommend Favorite